Therapy for Australian cats with lymphosarcoma.

Aust Vet J 2001 Dec;79(12):808-17

Department of Veterinary Clinical Sciences, Faculty of Veterinary Science, The University of Sydney, New South Wales.

Objective: To determine the response of Australian cats with lymphosarcoma to chemotherapy and/or surgery in relation to patient and tumour characteristics, haematological and serum biochemical values and retroviral status.

Design: Prospective study of 61 client-owned cats with naturally-occurring lymphosarcoma subjected to multi-agent chemotherapy and/or surgery.

Procedure: An accepted chemotherapy protocol utilising l-asparaginase, vincristine, cyclophosphamide, doxorubicin, methotrexate and prednisolone was modified and used to treat 60 cats with lymphosarcoma. Clinical findings were recorded before and during therapy. As far as practical, cases were followed to death, euthanasia or apparent cure. Owner satisfaction with the results of chemotherapy was determined using a questionnaire sent after the completion of chemotherapy.

Results: One cat, with lymphosarcoma limited to a single mandibular lymph node, was treated using surgery alone and was cured. The other 60 cats were treated using multi-agent chemotherapy, although seven cats with localised intestinal, ocular and subcutaneous lesions had these lesions partially (2 intestinal lesions) or completely (2 eyes, 2 intestinal lesions and a cluster of regional lymph nodes) resected prior to starting chemotherapy. The median survival time for these 60 cats was 116 days. Of the 60 cats, 48 rapidly went into complete remission following the administration of 1-asparaginase, vincristine and prednisolone (complete remission rate 80%) and these cats had a median survival of 187 days. Three cats were censored from further analysis as their long-term survival data were uninterpretable because they died of causes unrelated to lymphosarcoma or were prematurely lost to follow-up. Twenty cats were classed as 'long-term survivors' based on survival time in excess of one year and at least 14 were 'cured' based on the absence of physical evidence of lymphosarcoma 2-years after initiating treatment. In other words, of the 48 cats that reached complete remission, in excess of 29% were 'cured'. Despite detailed analysis, few meaningful prognostic indicators based on patient or tumour characteristics were identified, although long-term survivors were more likely to be less than 4-years (P= 0.04) and to have tumours of the T-cell phenotype (P= 0.06). Excluding the one FeLV ELISA-positive cat with mediastinal LSA, 7 of 9 cats less than 4 years-of-age were long-term survivors (median survival time >1271 days). There was a strong association between achieving complete remission and long-term survival (P = 0.003). On the basis of 27 replies to a questionnaire, owners were generally very satisfied with the response to chemotherapy, irrespective of the survival time of the individual patient. Eighty five percent of owners expressed complete satisfaction with their decision to pursue chemotherapy and 70% believed their cat's health status improved during the first 2-weeks of treatment. Importantly, 78% of owners considered that chemotherapy required a very substantial time commitment on their part.

Conclusions: It was possible to cure approximately one quarter of cats with lymphosarcoma using sequential multi-agent chemotherapy and/or surgery. FeLV-negative cats younger than 4 years (typically with mediastinal lymphosarcoma) had a particularly favourable prognosis. The decision to embark on chemotherapy should be based on the results of induction chemotherapy with l-asparaginase, vincristine and prednisolone, as the response to this was a good predictor of long-term survival. Cats surviving the first 16 weeks of chemotherapy generally enjoyed robust remissions (in excess of 1 year) or were cured of their malignancy.

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
December 2001
7 Reads

Publication Analysis

Top Keywords

survival time
16
complete remission
16
cats lymphosarcoma
16
cats
16
chemotherapy
13
multi-agent chemotherapy
12
median survival
12
chemotherapy and/or
12
long-term survival
12
lymphosarcoma
9
and/or surgery
8
tumour characteristics
8
intestinal lesions
8
long-term survivors
8
l-asparaginase vincristine
8
patient tumour
8
vincristine prednisolone
8
survival
8
australian cats
8
excess year
8

Similar Publications

Bactericidal Efficacy of Hydrogen Peroxide-Based Disinfectants Against Gram-Positive and Gram-Negative Bacteria on Stainless Steel Surfaces.

J Food Sci 2017 Oct 23;82(10):2351-2356. Epub 2017 Aug 23.

Dept. de Ciència Animal i dels Aliments, Facultat de Veterinària, Univ. Autònoma de Barcelona, Travessera dels Turons s/n. Bellaterra, CP, 08193, Barcelona, Spain.

In order to develop disinfectant formulations that leverage the effectiveness of hydrogen peroxide (H O ), this study evaluated the bactericidal efficacy of hydrogen peroxide-based disinfectants against Gram-positive and Gram-negative bacteria on stainless steel surfaces. Low concentration of hydrogen peroxide as 0.5% with a cationic polymer, ethoxylated fatty alcohol, and ethyl alcohol had bactericidal efficacy (reductions ≥ 4 log CFU/mL) against Escherichia coli, Staphylococcus aureus, Enterococcus hirae, and Pseudomonas aeruginosa. Read More

View Article
October 2017
19 Reads
1 PubMed Central Citation(source)
1.70 Impact Factor

National health insurance subscription and maternal healthcare utilisation across mothers' wealth status in Ghana.

Health Econ Rev 2017 Dec 26;7(1):16. Epub 2017 Apr 26.

Department of Population and Health, Faculty of Social Sciences, University of Cape Coast, Cape Coast, Ghana.

Introduction: This study is against the backdrop that despite the forty-nine percent decline in Maternal Mortality Rate in Ghana, the situation still remains high averaging 319 per 100,000 live births between 2011 and 2015.

Objective: To examine the relationship between National Health Insurance and maternal healthcare utilisation across three main wealth quintiles (Poor, Middle and Rich).

Methods: The study employed data from the 2014 Ghana Demographic and Health Survey. Read More

View Article
December 2017
15 Reads

A biophysical model of the cortex-basal ganglia-thalamus network in the 6-OHDA lesioned rat model of Parkinson's disease.

J Comput Neurosci 2016 Apr 11;40(2):207-29. Epub 2016 Feb 11.

Department of Biomedical Engineering, Duke University, 136 Hudson Hall, Box 90281, Durham, NC, 27708, USA.

Electrical stimulation of sub-cortical brain regions (the basal ganglia), known as deep brain stimulation (DBS), is an effective treatment for Parkinson's disease (PD). Chronic high frequency (HF) DBS in the subthalamic nucleus (STN) or globus pallidus interna (GPi) reduces motor symptoms including bradykinesia and tremor in patients with PD, but the therapeutic mechanisms of DBS are not fully understood. We developed a biophysical network model comprising of the closed loop cortical-basal ganglia-thalamus circuit representing the healthy and parkinsonian rat brain. Read More

View Article
April 2016
23 Reads
6 PubMed Central Citations(source)
1.74 Impact Factor

[The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province].

Zhonghua Liu Xing Bing Xue Za Zhi 2013 Feb;34(2):133-6

National Centre for Epidemiology and Population Health, Australian National University, Australia.

Objective: To investigate the long term survival of MDR-TB patients compared to non-MDR-TB in Henan province in 2010.

Methods: Participants were randomly selected in 2010 from a dataset generated by an anti-TB drug resistance surveillance survey conducted by the Tuberculosis Control Institute, Henan Centre for Disease Control and Prevention in 2001, supported by the World Health Organization. Information on patient's demographic profile and medical records was extracted by trained doctors and nurses at local anti-TB dispensaries. Read More

View Article
February 2013
32 Reads

Characterization and performance of immobilized amylase and cellulase.

Appl Biochem Biotechnol 2004 ;113-116:251-9

Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario, Canada M5S 3E5.

The performance of cellulase and amylase immobilized on siliceous supports was investigated. Enzyme uptake onto the support depended on the enzyme source and immobilization conditions. For amylase, the uptake ranged between 20 and 60%, and for cellulase, 7-10%. Read More

View Article
July 2004
2 Reads
1.74 Impact Factor